TROY EDWARD WILSON
CIK 1589597 · President and CEO · last filed 2026-03-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.00M
Companies
5
Total Filings
67
Lifetime Open-Market Net
-$24.78M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KURA | President and CEO | 714,650 | $9.05 | $6.47M | -$18.19M | 30 | 2026-03-25 |
| Avidity Biosciences, Inc. (RNAM) Delisted | Director | 0 | — | — | $0 | 1 | 2026-02-27 |
| RNA | Director | 97,636 | $12.37 | $1.21M | -$5.75M | 10 | 2025-09-09 |
| PBYI | Director | 43,950 | $7.33 | $322.2K | -$836.0K | 20 | 2025-06-17 |
| Zosano Pharma Corp (ZSAN) Delisted | Director | 3,000 | $0.56 | $1.7K | $0 | 5 | 2019-07-18 |
Recent Filings · Page 4 of 7
67 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-16 | RNA | Grant (A) | — | $0 | EDGAR |
| 2021-06-11 | PBYI | Sell (S) | −25,748 | -$292.4K | EDGAR |
| 2021-01-28 | KURA | Mixed | −175,000 | $0 | EDGAR |
| 2020-12-28 | RNA | Other (J) | — | $0 | EDGAR |
| 2020-12-02 | KURA | Exer (M) | +11,855 | $72.9K | EDGAR |
| 2020-10-08 | KURA | Mixed | −206,736 | -$8.36M | EDGAR |
| 2020-09-15 | KURA | Mixed | −98,975 | -$3.24M | EDGAR |
| 2020-09-10 | KURA | Mixed | −51,025 | -$2.14M | EDGAR |
| 2020-08-26 | KURA | Mixed | — | -$487.5K | EDGAR |
| 2020-08-19 | KURA | Mixed | −50,000 | -$1.54M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.